1. |
Nakayama M, Nawa T, Chonan T, et al. Prevalence of pulmonary arteriovenous malformations as estimated by low-dose thoracic CT screening. Intern Med, 2012, 51(13): 1677-1681.
|
2. |
Faughnan ME, Palda VA, Garcia-Tsao G, et al. HHT Foundation International - Guidelines Working Group. International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet, 2011, 48: 73-87.
|
3. |
Shovlin CL, Guttmacher E, Buscarini E, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet, 2000, 91: 66-67.
|
4. |
Hsu CC, Kwan GN, Thompson SA. Embolisation for pulmonary arteriovenous malformation. Cochrane Database Syst Rev, 2012, 8: CD008017.
|
5. |
Howard LS, Santhirapala V, Murphy K, et al. Cardiopulmonary exercise testing demonstrates maintenance of exercise capacity in patients with hypoxemia and pulmonary arteriovenous malformations. Chest, 2014, 146: 709-718.
|
6. |
Finnamore H, Le Couteur J, Hickson M, et al. Hemorrhage-adjusted iron requirements, hematinics and hepcidin define hereditary hemorrhagic telangiectasia as a model of hemorrhagic iron deficiency. PLoS ONE, 2013, 8: e76516.
|
7. |
Shovlin CL. Pulmonary arteriovenous malformations. Am J Respir Crit Care Med, 2014, 190: 1217-1228.
|